The Calciphylaxis Market is projected to witness steady growth through 2034, driven by increasing awareness of rare diseases, advances in targeted therapeutic development, and improvements in diagnostic capabilities. Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a rare but life-threatening vascular disorder characterized by calcification of small blood vessels, tissue...
The companion diagnostics market is becoming increasingly important as healthcare moves from broad treatment approaches toward precision medicine and biomarker-guided therapies. The market was valued at USD 9.6 billion in 2025 and is projected to grow from USD 10.3 billion in 2026 to USD 20.1 billion by 2033, registering a CAGR of 10.1% from 2026 to 2033. Increasing demand for precision...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek